Randomized phase II trial of combination idiotype vaccine and anti-CD3/anti-CD28 costimulated autologous T cells in patients with multiple myeloma post-autotransplantation
Muzaffar H. Qazilbash(The University of Texas MD Anderson Cancer Center), Larry W. Kwak(The University of Texas MD Anderson Cancer Center), Medhavi Honhar(The University of Texas MD Anderson Cancer Center), Adam D. Cohen(Penn Center for AIDS Research), Edward A. Stadtmauer(University of Pennsylvania), Alfred L. Garfall(University of Pennsylvania), Robert Z. Orlowski(University of North Carolina at Chapel Hill), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Nina Shah(The University of Texas MD Anderson Cancer Center), Elizabeth J. Shpall(Scripps MD Anderson Cancer Center), Krina K. Patel(University of Vermont), Beryl Tross(The University of Texas MD Anderson Cancer Center), Karen Dengel(Parker Institute for Cancer Immunotherapy), Qaiser Bashir(The University of Texas MD Anderson Cancer Center), Kunhwa Kim(The University of Texas MD Anderson Cancer Center), Michael Popescu(The University of Texas MD Anderson Cancer Center), Veera Baladandayuthapani(The University of Texas MD Anderson Cancer Center), Jatin J. Shah(The University of Texas MD Anderson Cancer Center), Soung-chul Cha(The University of Texas MD Anderson Cancer Center), Naseem Kerr(Parker Institute for Cancer Immunotherapy), Sheetal Rao(The University of Texas MD Anderson Cancer Center), Carl H. June(University of Pennsylvania), Donna Weber(The University of Texas MD Anderson Cancer Center), Sheeba K. Thomas(The University of Texas MD Anderson Cancer Center)
Cited by 5
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940